Exploiting Alternative Brush Border Trafficking Routes to Treat Microvillous Inclusion Disease

Gastroenterology. 2020 Oct;159(4):1233-1235. doi: 10.1053/j.gastro.2020.08.006. Epub 2020 Aug 7.

Authors

Shabnam Abtahi¹, Jerrold R Turner²

Affiliations

¹ Laboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Laboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: jrturner@bwh.harvard.edu.

PMID: 32777279
DOI: 10.1053/j.gastro.2020.08.006

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Cytomegalovirus Infections*
Lysophospholipids
Malabsorption Syndromes
Mice
Microvilli / pathology
Mucolipidoses*
Myosin Type V*

Substances

Lysophospholipids
Myo5B protein, mouse
Myosin Type V
lysophosphatidic acid

Supplementary concepts

Microvillus inclusion disease

Grants and funding